Latest news with #BarchartBrief
Yahoo
2 hours ago
- Business
- Yahoo
How is Cooper Companies' Stock Performance Compared to Other Medical Instruments & Supplies Stocks?
San Ramon, California-based The Cooper Companies, Inc. (COO) is a global medical device company that develops, manufactures, and markets contact lenses. With a market cap of around $14 billion, the company operates in two segments, CooperVision and CooperSurgical. Companies worth $10 billion or more are generally described as 'large-cap' stocks, and Cooper Companies fits this criterion perfectly. The company specializes in contact lenses and eye care products, and also offers a wide range of medical devices and fertility solutions for women's health. It focuses on innovation, patient outcomes, and global expansion to drive long-term growth across healthcare markets. OpenAI CEO Sam Altman Says 'We Are Heading Towards a World Where AI Will Just Have Unbelievable Context on Your Life' Archer Aviation Is Betting Big on Its Fledgling Defense Business. Does That Make ACHR Stock a Buy Here? Unusual Call Options Activity in Marvell Technology Highlights the Value of MRVL Stock Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Shares of Cooper Companies have declined 37.9% from its 52-week high of $112.38. COO stock has dropped 12.8% over the past three months, a steeper decline than the First Trust Indxx Global Medical Devices ETF's (MDEV) 2.3% decrease. Longer term, shares of COO have plunged 24.1% on a YTD basis, notably underperforming MDEV's nearly 2.7% downtick over the same time frame. Moreover, Cooper's stock has fallen 23.8% over the past 52 weeks, compared to MDEV's marginal dip. Despite some fluctuations, the stock has been trading below its 50-day moving average since late October last year and its 200-day moving average since early December last year. Despite posting strong Q2 2025 results on May 29, shares of COO tumbled 14.6% the next day. Quarterly revenue rose 6.3% year-over-year to $1 billion, exceeding Street expectations, while adjusted EPS increased 19.6% year-over-year to $0.96, also beating estimates. However, the stock declined as the company lowered its full-year organic growth outlook to 5% to 6%, down from the previous forecast of 6% to 8%, which dampened investor sentiment. Compared to its rival, Align Technology, Inc. (ALGN) has slightly underperformed the COO stock over the past 52 weeks, decreasing 25.7%. However, shares of ALGN have declined 13.7% YTD, a less pronounced dip compared to COO stock. Although COO has underperformed, analysts are moderately optimistic about its prospects. The stock has a consensus rating of 'Moderate Buy' from the 16 analysts covering the stock. As of writing, the stock is trading below the mean price target of $94.87. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Business
- Yahoo
How Is Waters Corporation's Stock Performance Compared to Other Healthcare Stocks?
With a market cap of $20.2 billion, Waters Corporation (WAT) is a global leader in analytical instruments and laboratory solutions. Operating through its Waters and TA Divisions, the company designs, manufactures, and services high-performance liquid chromatography, mass spectrometry, and thermal analysis systems. Companies valued at more than $10 billion are generally considered 'large-cap' stocks, and Waters Corporation fits this criterion perfectly. Its innovative products support pharmaceutical, life science, industrial, and governmental customers across Asia, the Americas, and Europe in research, development, and quality assurance applications. OpenAI CEO Sam Altman Says 'We Are Heading Towards a World Where AI Will Just Have Unbelievable Context on Your Life' Archer Aviation Is Betting Big on Its Fledgling Defense Business. Does That Make ACHR Stock a Buy Here? Unusual Call Options Activity in Marvell Technology Highlights the Value of MRVL Stock Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Shares of the Milford, Massachusetts-based company have fallen 19.9% from its 52-week high of $423.56. Over the past three months, shares of WAT have declined 11.2%, underperforming the 9.3% dip of the Health Care Select Sector SPDR Fund (XLV) during the same period. Longer term, WAT stock is down 8.5% on a YTD basis, a steeper decline than XLV's 3.2% drop. However, shares of Waters Corporation have returned 15.3% over the past 52 weeks, surpassing XLV's 8.7% decline over the same time frame. The stock has been trading below its 200-day moving average since April. Despite reporting better-than-expected Q1 2025 adjusted EPS of $2.25 and revenue of $661.7 million, WAT shares fell 2.7% on May 6, likely due to investor concerns over macroeconomic uncertainties and tariff impacts. However, the company raised its full-year adjusted EPS guidance to $12.75 - $13.05 and constant currency sales growth to 5% - 7%. WAT stock has outperformed its rival, Thermo Fisher Scientific Inc. (TMO). TMO stock has fallen 31% over the past 52 weeks and 24.5% on a YTD basis. Despite the stock's outperformance over the past year, analysts are cautiously optimistic about its prospects. The stock has a consensus rating of 'Moderate Buy' from the 18 analysts covering the stock, and as of writing, it is trading below the mean price target of $393. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
4 hours ago
- Business
- Yahoo
2 Outstanding Stocks Under $50 to Buy and Hold Now
Not all great growth stocks come with a sky-high price tag. In fact, some of the most promising companies in today's market are trading for less than $50 per share, demonstrating that investors don't have to break the bank to accumulate long-term wealth. The two stocks on this list have strong fundamentals, attractive valuations, and compelling growth prospects, making them ideal for a buy-and-hold strategy. Let's take a look at two standout picks that provide significant upside potential without a hefty price. 'It Has No Utility': Warren Buffett Doesn't Care How High Gold Goes, He Isn't a Buyer OpenAI CEO Sam Altman Says 'We Are Heading Towards a World Where AI Will Just Have Unbelievable Context on Your Life' Archer Aviation Is Betting Big on Its Fledgling Defense Business. Does That Make ACHR Stock a Buy Here? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Valued at a market capitalization of $3.5 billion, Semtech (SMTC) is a chipmaker and connectivity innovator specializing in analog/mixed-signal semiconductors and IoT systems, particularly its LoRa technology. Semtech reported strong first-quarter fiscal year 2026 results, signaling a turning point in the company's post-pandemic transformation. However, SMTC stock is down 32% year-to-date, indicating that now may be a good time to buy shares on the dip. During the Q1 earnings call, CEO Hong Hou emphasized the company's adaptability and resilience in the face of geopolitical uncertainties such as U.S.-China trade tensions and supply-chain volatility. Total revenue for the quarter increased 22% year on year to $251.1 million. Adjusted earnings per share increased to $0.38 as well, up from $0.06 in the prior year quarter. Semtech's infrastructure business outperformed expectations with record revenue of $51.6 million, up 143% year on year. This growth was driven by rising demand for artificial intelligence (AI) workloads and next-generation compute clusters. Notably, CopperEdge, a disruptive active copper cable (ACC) technology designed for AI data centers, contributed to this expansion. Management stated that CopperEdge's production ramp is expected to begin in the latter half of fiscal 2026, positioning it as a significant revenue contributor by year-end. In the firm's Industrial segment, IoT hardware and LoRa drove revenue growth of 24%. LoRa-enabled revenue reached $38.9 million (up 81% year on year), reflecting strong demand from new verticals such as healthcare, wearables, and robotics. The company generated $26.2 million in free cash flow, allowing it to pay down debt by $10 million in the first quarter and an additional $15 million in the second quarter to date. Semtech is developing a multi-pronged growth engine with a strengthened infrastructure pipeline, IoT platforms designed for scale, and an increasing presence in AI-enabling technologies. Analysts predict that Semtech's earnings will rise by 88.6% in fiscal 2026, followed by an additional 29.5% the following fiscal year. Semtech, trading at 24x forward earnings, is a reasonable AI-led growth stock to buy right now. On Wall Street, Semtech stock remains a 'Strong Buy.' Out of the 14 analysts who cover SMTC stock, 10 rate it a 'Strong Buy,' one calls it a 'Moderate Buy," and three suggest a 'Hold" rating. Based on the mean price target of $56.33, Semtech stock has upside potential of 34% from current levels. Plus, the high target price of $68 suggests that shares could rally as much as 62% over the next 12 months. The second stock on this list is Toast (TOST), a cloud-focused tech company that offers an end-to-end platform combining software, hardware, and financial services to help restaurants run more efficiently. Toast stock, valued at $21.1 billion, is up 16.8% year to date, outperforming the 1.9% gain in the broader market. However, the stock is trading 6.5% below its 52-week high, making it an excellent time to buy on a dip. Currently, Toast has 140,000 locations on the platform (up 25% year on year), with an additional 6,000 added in the first quarter of 2025. Annual recurring revenue increased 31% YOY to $1.7 billion. Recurring revenue and rapid customer acquisition lay a solid foundation for long-term growth. Toast is transitioning from investment-driven growth to consistent profitability, which is an ideal scenario for long-term investors. In Q1, GAAP net income stood at $56 million versus a GAAP net loss of $83 million in the year-ago quarter. Adjusted EBITDA climbed from $57 million in the prior-year quarter to $133 million. Free cash flow improved dramatically as well, from -$33 million to $69 million. The company ended the quarter with a healthy balance sheet, sporting no debt and a cash balance of $1 million. Analysts predict that revenue will grow by 20% to 21% per year over the next two years. Earnings could increase by 70% in 2025, then by 31% the following year. TOST stock appears to be overpriced at 46x forward earnings, but this reflects investors' confidence in the company's future growth prospects. Toast integrates seamlessly with restaurant operations, including point-of-sale (POS) and kitchen management, payroll, inventory, loyalty, and analytics. In the POS systems market alone, the company has a 24.4% market share. Priced under $50 per share and combining accelerating recurring revenue, profitability, solid fundamentals, and a long-term business moat, TOST stock is a strong candidate for a buy-and-hold investment strategy. Overall, Wall Street rates Toast stock as a 'Moderate Buy.' Out of the 29 analysts who cover the stock, 13 have given it a 'Strong Buy' rating while one analysts says it is a 'Moderate Buy" and 15 suggest a 'Hold" rating. Based on the mean target price of $44.04, Toast stock has upside potential of 3.6% from current levels. However, the high target price of $52 suggests that the stock could rise more than 22% over the next 12 months. On the date of publication, Sushree Mohanty did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
4 hours ago
- Business
- Yahoo
Is Synchrony Financial Stock Outperforming the Nasdaq?
Stamford, Connecticut-based Synchrony Financial (SYF) is a premier consumer financial services company delivering one of the industry's most complete digitally-enabled product suites. Valued at $22.9 billion by market cap, the company provides a range of credit products such as credit cards, commercial credit products, and consumer installment loans through programs established with a diverse group of national and regional retailers, local merchants, manufacturers, and more. Companies worth $10 billion or more are generally described as 'large-cap stocks,' and SYF perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the credit services industry. SYF's market leadership is fueled by its vast partner network, comprising national retailers, local merchants, and healthcare providers, paired with a robust digital platform. This digital focus aligns with consumer trends and enhances customer engagement. 'It Has No Utility': Warren Buffett Doesn't Care How High Gold Goes, He Isn't a Buyer OpenAI CEO Sam Altman Says 'We Are Heading Towards a World Where AI Will Just Have Unbelievable Context on Your Life' Archer Aviation Is Betting Big on Its Fledgling Defense Business. Does That Make ACHR Stock a Buy Here? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! Despite its notable strength, SYF shares have slipped 13.4% from their 52-week high of $70.93, achieved on Jan. 23. Over the past three months, SYF stock has gained 15.8%, outperforming the Nasdaq Composite's ($NASX) 11.7% gains during the same time frame. In the longer term, shares of SYF dipped 5.5% on a YTD basis, underperforming NASX's YTD gains of 1.2%. However, the stock climbed 40.8% over the past 52 weeks, outperforming NASX's 9.4% returns over the last year. To confirm the bullish trend, SYF has been trading above its 200-day moving average since mid-May, with slight fluctuations. The stock is trading above its 50-day moving average since early May. SYF is experiencing strong performance driven by interest on credit card balances and consumer loans. The Fed pausing rate cuts is expected to increase loan yields, boosting net interest income. In addition, strategic acquisitions and partnerships are driving digital transformation and product diversification, with rapid expansion of the CareCredit platform in healthcare and collaborations in the pet care market, showing strong growth potential. Moreover, partnerships with industry leaders like PayPal Holdings, Inc. (PYPL), Venmo, and Mastercard Incorporated (MA) have improved the customer payment experience. On Apr. 22, SYF shares closed up more than 2% after reporting its Q1 results. Its EPS of$1.89 exceeded Wall Street expectations of $1.63. The company's net interest income was $4.5 billion, falling short of Wall Street forecasts of $4.6 billion. In the competitive arena of credit services, American Express Company (AXP) has taken the lead over SYF, showing resilience with a marginal downtick on a YTD basis but lagged behind the stock with 29.3% gains over the past 52 weeks. Wall Street analysts are moderately bullish on SYF's prospects. The stock has a consensus 'Moderate Buy' rating from the 23 analysts covering it, and the mean price target of $64.59 suggests a potential upside of 5.1% from current price levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Business
- Yahoo
Warren Buffett Famously Warned to 'Make Money While You Sleep' or 'You Will Work Until You Die': 5 Stocks To Invest Like Buffett
Most people spend their lives exchanging time for money, but Warren Buffett's famous warning—'If you don't find a way to make money while you sleep, you will work until you die' — captures the essence of building lasting wealth through passive income. For Buffett and many successful investors, one of the most reliable paths to earning money around the clock is investing in high-quality dividend stocks, or stocks with consistent returns and appreciation. Buffett's approach to dividend investing is rooted in the pursuit of long-term, sustainable wealth. He gravitates toward companies that not only pay consistent dividends but also have a track record of increasing those payouts over time. What makes this strategy powerful is its ability to generate passive income — money that flows into your account whether the market is up or down, and regardless of your day-to-day involvement. How a Stablecoin Could Absolutely Transform This 'Strong Buy' Dividend King Warren Buffett Famously Warned to 'Make Money While You Sleep' or 'You Will Work Until You Die': 5 Stocks To Invest Like Buffett Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Dividend stocks, when chosen wisely, allow investors to participate in the profits of established businesses. This steady stream of income can be reinvested for compounding growth or used to fund living expenses, making it possible to gradually shift from working for money to letting your money work for you. Buffett's own portfolio is a testament to the value of dividend investing. Below are the names of some of his biggest positions, and others with strong dividends. A cornerstone of Buffett's portfolio, Coca-Cola has paid and increased its dividend for decades. In 2024 alone, Berkshire Hathaway received nearly $776 million in dividends from Coca-Cola, a testament to the power of holding quality dividend payers over the long term. Coca-Cola is currently yielding a respectable 2.88% dividend, and coupled with its strong and consistent stock appreciation, it's a no-brainer for any portfolio. Currently offering a whopping 6.5% dividend, a $10,000 investment in Verizon could net you $650 in income every year. Coupled with respectable returns amidst an ongoing rebound, this could prove to be a strong value proposition for investors. While not currently in Buffett's portfolio, he does own competitor T-Mobile, meaning Berkshire Hathaway is bullish on some telecoms, at least. While Apple's dividend yield is modest, its consistent growth and massive cash flows make it a reliable source of income and capital appreciation. Even among its struggles, AAPL is one of the top-performing stocks in history. You're not going to make it rich on the dividends alone, but it's one of the most innovative companies on the planet, so it's a safe and consistent bet. As one of Berkshire Hathaway's top holdings for several years now, it's a testament to just how much the company has going for it. Ford's stock performance is nothing to write home about, but it's got a great dividend for a company with a lot of potential growth avenues. The stock has been hovering around $10 for nearly 30 years, but a good entry point and nearly 6% dividend looks tempting. While Buffett has previously said he thinks the industry is just 'too tough,' Berkshire did buy a 10% stake in Chinese automaker BYD (BYDDY) a while back, which netted astronomical returns for Berkshire. Ford's growth story isn't the most enticing, but Jim Farley's leadership seems to be turning things around for the most part. It might take a few more years, but in the meantime, you can sit and enjoy a steady dividend income. Chevron might not look enticing to most in the modern era of electric vehicles, nuclear fusion power, and renewable energy. But Buffett is more convinced than ever, with the stock making up 7.67% of the Berkshire portfolio. Considering Chevron's 4.63% dividend and 63% stock growth in 5 years, it's not hard to see why he loves it. Buffett's strategy is not to chase the highest yields, but to focus on the underlying quality of the business. He prefers companies with strong competitive advantages, stable earnings, and prudent management — traits that support both dividend stability and long-term growth. To follow in Buffett's footsteps, investors should: Seek consistency: Prioritize companies with a long history of paying and growing dividends, as this signals financial health and a shareholder-friendly culture. Focus on business quality: Look for companies with durable competitive advantages ('moats'), strong cash flows, and simple, understandable business models. Diversify: While Buffett often concentrates his holdings, most investors benefit from diversifying across sectors and geographies to reduce risk. Reinvest dividends: Compounding works best when dividends are reinvested, accelerating portfolio growth over time. Some of Buffett's favorite dividend stocks—such as Coca-Cola, Procter & Gamble, and Apple — offer a blueprint for building a portfolio that generates income while you sleep. Buffett's advice is both a warning and an opportunity. By building a portfolio of high-quality dividend stocks, investors can harness the power of compounding, enjoy a steady stream of passive income, and ultimately achieve the financial freedom to make money — even while they sleep. On the date of publication, Caleb Naysmith did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
